Roche Holding AG Receivables 2010-2023 | RHHBY

Roche Holding AG receivables for the quarter ending December 31, 2023 were $12.276B, a 1.25% decline year-over-year.

  • Roche Holding AG receivables for 2023 were $12.276B, a 0.94% increase from 2022.
  • Roche Holding AG receivables for 2022 were $12.162B, a 2.87% increase from 2021.
  • Roche Holding AG receivables for 2021 were $11.823B, a 9.16% increase from 2020.

Roche Holding AG Receivables 2010-2023 | RHHBY

  • Roche Holding AG receivables for 2023 were $12.276B, a 0.94% increase from 2022.
  • Roche Holding AG receivables for 2022 were $12.162B, a 2.87% increase from 2021.
  • Roche Holding AG receivables for 2021 were $11.823B, a 9.16% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$763.3B
Novo Nordisk (NVO)$377.1B
Johnson & Johnson (JNJ)$363.9B
AbbVie (ABBV)$309.7B
Merck (MRK)$248.6B
AstraZeneca (AZN)$217.9B
Novartis AG (NVS)$210.4B
Pfizer (PFE)$150.9B
Sanofi (SNY)$132.3B
Bayer (BAYRY)$22.2B
Innoviva (INVA)$1.2B